Page 877 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux

834 MÉDICAMENTS £ZV RELA TION A VEC DES SYSTÈMES HORMONA UX

-1a-OH-D3, 651,658, 662 - (23S,25R)-1a,25- (OH)2-D3-26,23-lactone,
-1P-OH-D3, 644, 647,651 635
- 2P-OH-D3, 644, 646, 647 -1a,25- (OH)2-24,24-diméthyl-D3, 642
- 24S-OH-D3, 651 - 1a.25-(OH)2-26,27-diméthyl-D3, 642
- 25-OH-D3, 634, 636, 637, 644, 650, 651, - 1 a,25-(OH)2-24,24-diméthyl-22E-déshydro-
655, 657, 662, 663 D3, 642
- (25R)-26-OH-D3, 638, 639 - 1a,25-(OH)2-24-méthy1-D3, 642
- (25S)-26-OH-D3, 638. 639 - 24-nor-1a,25-(OH)2-D3, 651
- 23,24-bi nor-25-OH-D3, 641 • Dérivés trihydroxylés
- 26,27-bi nor-25-OH-D3. 641 - (23S)-1 a,23,25-(OH)3-D3, 635. 636
- 24-nor-25-OH-D3, 641 - 1a.24,25-(OH)3-D3, 635
- 27-nor-25-OH-D3, 641 - (24R)-1a.24,25-(OH)3-D3, 636. 638, 653
- 20-21,22,23,24-pentanor-25-OH-D3, 641 - (24S)-1 a-24,25-(OH)3-D3, 639, 651
- 5,6-trans-25-OH-D3, 651 - (23S,25R)-23,25,26-(OH)3-D3, 637
- 22,23,24-trinor-25-OH-D3, 641 - 1a,25,26-(OH)3-D3. 635
- Hydroxyestrone, 424 - 1a,25R,26-(OH)3-D3, 651
-16a-Hydroxyestrone, 447 - (25S)-1 a-25,26-(OH)3-D3, 636, 651
-1 a-Hydroxypregnénolone, 624 - 23,24,25-(OH)3-D3, 635, 637
-17a-Hydroxypregnénolone, 554 - 23,25,26-(OH)3-D3, 635
- Hydroxyprogestérone, 509, 525, 526 - 24,25,26-(OH)3-D3, 637
- 17a-Hydroxyprogestérone. 506, 522, 534 Hydroxylases
- 17-Hydroxyprogestérone (caproate de), - 25-Hydroxycholécalciférol-1 a- hydroxylase,
523 656
• Dérivés dihydroxylés - 1 a-hydroxylase, 634
- 1a,25-dihydroxycholécalciférol, 611,670, - 1-a-25-(OH)2-D3 Hydroxylase, 677
684, 693 -11 P-Hydroxylase, 418
- (24R)-1a,24- (OH)2-D3, 646, 651 - 17a-Hydroxy1ase, 418, 554
- 1a,24S-(OH)2-D3, 651 -17a-Hydroxylase (inhibiteurs de la), 577
- 1 a,24R-(OH)2-A-22-D3. 651 -18-Hydroxylase, 418
- 1 a,25-(OH)2-D3, 636, 649-652, 655-658, - 1 a-Hydroxylase, 657, 662
662. 663 - 21-Hydroxylase, 418
- ip,25-(OH)2-D3, 644, 647, 651 -24-Hydroxylase, 634, 657
- (22E,24R)-1a,24-(OH)2-A-22-D3, 640 - 25-Hydroxylase, 634, 646, 657
- (22E,24S)-1a,24-(OH)2-A-22-D3, 639 - Stéroïde-11 p-hydroxylase, 490
- (22R)-22,25-(OH)2-D3, 639, 651 -Stéroïde-18-hydroxylase, 490
- (22S)-22,25-(OH)2-D3, 639, 651 N-Hydroxyphénylrétinamide, 817
-23,25-(OH)2-D3, 635 17-Hydroxyprogestérone (Caproate de), 523
- 23R,25-(OH)2-D3, 651 Hydroxypropylméthylcellulose (HPMC), 223
- (23S)-23,25-(OH)2-D3, 636. 637, 651 N-Hydroxysuccinimide (Esters de), 364,374
- 24,25-(OH)2-D3, 650, 657 Hyperinsulinémie, 55
- (24R)-24,25-(OH)2-D3, 634, 636. 637, 651, Hyperuricémies, 1, 6
653 Hypervitaminose A, 786, 815
- (24S)-24,25-(OH)2-D3, 635, 637, 651 Hypoxanthine, 1
- 25,26-(OH)2-D3, 635, 638
- (25R)-25,26-(OH)2-D3, 636, 638
- 25R,26-(OH)2-D3, 651
- 24S.25-(OH)2-D3, 651 I
- (25S)-25,26-(OH)2-D3, 636, 651
- 1a,25- (OH)2-16-ène-23-yne-D3, 646 IC1105 552, 120
- 1a.25-(OH)2-26,27-diéthyl-D3, 642 ICI 164 384, 475
- 1a,25-(OH)2-24-homo-D3. 642 ICI 176 334, 586
- 1 a,25-(OH)2-A-22,A-24.26,27-homo-D3. ICI 182 780, 475
642 ICI D 1033. 496, 497
- 1a,25-(OH)2-2a-hydroxypropoxy-D3, 646 Idazoxan, 155